Feds put GSK manufacturing under supervision 2 years ago

While U.S. authorities earlier this week made a big splash over the $3 billion agreement with GlaxoSmithKline ($GSK) to settle a wide variety of claims that it used misleading marketing and bribes to…
Read the full story: News